avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tbx2
|
ENSMUSG00000000093.6 | T-box 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tbx2 | mm10_v2_chr11_+_85832551_85832551 | -0.63 | 3.9e-05 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.2 | 36.6 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
2.6 | 10.4 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.4 | 4.2 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
1.4 | 4.1 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
1.3 | 5.0 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
1.1 | 17.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.9 | 2.8 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.9 | 3.6 | GO:0030091 | protein repair(GO:0030091) |
0.8 | 3.2 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.7 | 2.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 2.6 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.6 | 1.9 | GO:0070104 | negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
0.6 | 1.9 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.6 | 3.6 | GO:0071486 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.5 | 5.9 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.5 | 3.7 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.5 | 2.6 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.5 | 1.9 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.5 | 3.7 | GO:0015871 | choline transport(GO:0015871) |
0.4 | 1.2 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.4 | 1.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.4 | 3.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 14.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.3 | 6.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.3 | 3.7 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.3 | 1.7 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.3 | 1.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 0.8 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 1.4 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.2 | 1.8 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
0.2 | 1.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 2.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 3.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 2.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 0.2 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.1 | 0.7 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 2.1 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 1.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 2.0 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 1.8 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.6 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.1 | 1.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.1 | 1.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 5.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 1.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.7 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 3.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 1.5 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 1.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 | 0.3 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 3.7 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 2.7 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 1.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 1.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.4 | GO:1903764 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) regulation of potassium ion export across plasma membrane(GO:1903764) |
0.1 | 0.7 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 8.4 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.1 | 1.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.7 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 | 2.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 4.9 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 2.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 1.9 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 2.0 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 9.3 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 2.0 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 1.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 1.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 1.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 2.8 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.0 | 1.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.3 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.0 | 1.9 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 9.3 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.9 | 36.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.6 | 1.9 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.5 | 2.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.5 | 2.6 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.4 | 1.2 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.3 | 1.5 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.3 | 2.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 0.7 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.2 | 1.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 1.7 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.2 | 3.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 6.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 4.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 3.2 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 2.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 2.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 1.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 2.7 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 5.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 1.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 5.0 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 1.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 1.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.4 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.0 | 1.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 3.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.9 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 6.3 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.0 | 1.1 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 2.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 1.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 17.3 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 36.6 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
3.5 | 10.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.9 | 2.7 | GO:0080122 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.8 | 3.2 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.7 | 2.0 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.6 | 13.5 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.6 | 1.9 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) leukemia inhibitory factor receptor activity(GO:0004923) interleukin-6 binding(GO:0019981) |
0.6 | 3.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.6 | 3.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.5 | 2.1 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.5 | 3.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.5 | 2.1 | GO:0042806 | fucose binding(GO:0042806) |
0.5 | 1.9 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.5 | 4.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.5 | 1.8 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.4 | 3.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 2.8 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 2.0 | GO:0005223 | intracellular cAMP activated cation channel activity(GO:0005222) intracellular cGMP activated cation channel activity(GO:0005223) |
0.3 | 2.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 1.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 1.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 1.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 4.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 1.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 1.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 2.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 1.9 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 1.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 3.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 1.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.2 | 2.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 4.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 1.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.7 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 2.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 1.5 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 17.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.2 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.1 | 0.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 2.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.3 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 2.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 3.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 5.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 2.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 4.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 4.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 3.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 3.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 2.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.9 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 1.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 1.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 1.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 1.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 3.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.4 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 6.0 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.0 | 1.8 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 1.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 2.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 3.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 1.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 39.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 3.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 1.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 6.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 2.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 4.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 1.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 3.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 1.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 3.2 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 7.9 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.5 | 9.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.4 | 10.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.3 | 3.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 6.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 7.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 3.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 4.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 2.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 3.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 1.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.9 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 1.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 4.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 2.1 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 1.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 2.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 2.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 2.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 9.7 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 2.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 2.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 2.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 3.6 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |